US Food and Drug Administration
Dr. Karen Li, PharmD, is currently a Contractor at U.S. Food and Drug Administration Center for Drug Evaluation and Research. She earned her PharmD from the University of Maryland School of Pharmacy. She currently conducts research on utility of pharmacogenomic information in generic drug development, specifically on assessing the impact of polymorphic cytochrome P450 enzymes on pharmacokinetics of oral dosage forms.